CTOs on the Move

Colon And Rectal Surgery Associates Ltd

www.colonrectal.org

 
Colon And Rectal Surgery Associates Ltd is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Paul, MN. To find more information about Colon And Rectal Surgery Associates Ltd, please visit www.colonrectal.org
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.colonrectal.org
  • 393 Dunlap St N Ste 500
    Saint Paul, MN USA 55104-4206
  • Phone: 651.312.1500

Executives

Name Title Contact Details

Similar Companies

The Great Falls Clinic

The Great Falls Clinic, LLP is a multi-specialty group medical facility emphasizing primary practice care, related secondary level medical specialties, and urgent care.

Modern Fertility

Modern Fertility tests are exclusively intended to be used for wellness purposes. The tests we offer are not intended to diagnose or treat disease, or to substitute for a physician`s consultation. Our tests are not available in New York, New Jersey, or Rhode Island.

Nature Coast Lodge

Nature Coast Lodge is a Lecanto, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clearview Healthcare Partners

Clearview Healthcare Partners is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.